Caris Life Sciences (CAI) Tax Rate (2026)
Caris Life Sciences (CAI) posted quarterly Tax Rate of 20.81% for Q1 2026.
Caris Life Sciences (CAI) Tax Rate (2026) Analysis & Trends
Caris Life Sciences' Tax Rate history runs 1 years deep, the most recent figure standing at 20.81% for Q1 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.97 Bn | 131.12 Bn | 2.84 Bn | 20.98% |
| 2 | Regeneron Pharmaceuticals | 85.15 Bn | 77.15 Bn | 3.93 Bn | 15.11% |
| 3 | Argenx Se | 62.84 Bn | 57.65 Bn | 1.37 Bn | 10.91% |
| 4 | Moderna | 55.74 Bn | 50.60 Bn | 52.00 Mn | -1.96% |
| 5 | BeOne Medicines | 41.53 Bn | 36.43 Bn | 1.53 Bn | 24.15% |
| 6 | Alnylam Pharmaceuticals | 31.60 Bn | 28.29 Bn | 992.69 Mn | 7.49% |
| 7 | BioNTech SE | 27.32 Bn | 8.93 Bn | 668.28 Mn | 34.12% |
| 8 | Royalty Pharma | 27.29 Bn | 26.45 Bn | - | - |
| 9 | Insmed | 26.99 Bn | 25.83 Bn | 358.27 Mn | -16.71% |
| 10 | Caris Life Sciences | 7.42 Bn | 6.63 Bn | 182.38 Mn | -3.75% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -3.75% |
| Jun 30, 2026 | -3.75% |
| Jun 30, 2026 | -3.75% |
| Mar 31, 2026 | 20.81% |
| Mar 31, 2026 | 20.81% |
| Mar 31, 2026 | 20.81% |